|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.8600 MYR | -4.44% |
|
+2.38% | +27.41% |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 45.79M | 47.95M | 68.3M | 75.46M | 113M | |||||
Total Revenues | 45.79M | 47.95M | 68.3M | 75.46M | 113M | |||||
Cost of Goods Sold, Total | 33.99M | 37.42M | 51.16M | 54.76M | 79.63M | |||||
Gross Profit | 11.8M | 10.54M | 17.14M | 20.71M | 33.85M | |||||
Selling General & Admin Expenses, Total | 4.02M | 5.01M | 5.2M | 6.28M | 9.9M | |||||
Other Operating Expenses | -499K | -631K | 68.82K | 354K | -256K | |||||
Other Operating Expenses, Total | 3.52M | 4.38M | 5.27M | 6.63M | 9.64M | |||||
Operating Income | 8.28M | 6.15M | 11.86M | 14.07M | 24.21M | |||||
Interest Expense, Total | -467K | -920K | -1.01M | -1.02M | -768K | |||||
Interest And Investment Income | 28.8K | 25.92K | 28.97K | 26.1K | 136K | |||||
Net Interest Expenses | -438K | -894K | -977K | -992K | -632K | |||||
Currency Exchange Gains (Loss) | 39.38K | 95.91K | 130K | 242K | - | |||||
Other Non Operating Income (Expenses) | -74.15K | -31.72K | -41.25K | -40.25K | -968K | |||||
EBT, Excl. Unusual Items | 7.81M | 5.32M | 10.98M | 13.28M | 22.61M | |||||
Gain (Loss) On Sale Of Assets | - | 110K | 254K | 13K | - | |||||
Insurance Settlements | 43K | - | - | 134K | 6.93K | |||||
EBT, Incl. Unusual Items | 7.85M | 5.43M | 11.23M | 13.43M | 22.61M | |||||
Income Tax Expense | 2.1M | 1.9M | 2.74M | 3.46M | 6.23M | |||||
Earnings From Continuing Operations | 5.75M | 3.54M | 8.49M | 9.97M | 16.39M | |||||
Net Income to Company | 5.75M | 3.54M | 8.49M | 9.97M | 16.39M | |||||
Net Income - (IS) | 5.75M | 3.54M | 8.49M | 9.97M | 16.39M | |||||
Net Income to Common Incl Extra Items | 5.75M | 3.54M | 8.49M | 9.97M | 16.39M | |||||
Net Income to Common Excl. Extra Items | 5.75M | 3.54M | 8.49M | 9.97M | 16.39M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 0.03 | 0.02 | 0.04 | 0.05 | 0.07 | |||||
Basic EPS - Continuing Operations | 0.03 | 0.02 | 0.04 | 0.05 | 0.07 | |||||
Basic Weighted Average Shares Outstanding | 216M | 216M | 216M | 216M | 237M | |||||
Net EPS - Diluted | 0.03 | 0.02 | 0.04 | 0.05 | 0.07 | |||||
Diluted EPS - Continuing Operations | 0.03 | 0.02 | 0.04 | 0.05 | 0.07 | |||||
Diluted Weighted Average Shares Outstanding | 216M | 216M | 216M | 216M | 237M | |||||
Normalized Basic EPS | 0.02 | 0.02 | 0.03 | 0.04 | 0.06 | |||||
Normalized Diluted EPS | 0.02 | 0.02 | 0.03 | 0.04 | 0.06 | |||||
Dividend Per Share | 0.02 | 0.01 | 0.01 | 0.01 | - | |||||
Payout Ratio | 86.91 | 85.5 | 25.44 | 21.66 | - | |||||
Supplemental Items | ||||||||||
EBITDA | 9.48M | 7.49M | 13.54M | 15.89M | 27.28M | |||||
EBITA | 8.28M | 6.15M | 11.86M | 14.07M | 24.21M | |||||
EBIT | 8.28M | 6.15M | 11.86M | 14.07M | 24.21M | |||||
EBITDAR | 9.48M | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 26.7 | 34.91 | 24.39 | 25.74 | 27.53 | |||||
Total Current Taxes | 2.03M | 1.18M | 2.94M | 3.79M | 5.14M | |||||
Total Deferred Taxes | 67.53K | 715K | -204K | -330K | 1.09M | |||||
Normalized Net Income | 4.88M | 3.33M | 6.86M | 8.3M | 14.13M | |||||
Interest on Long-Term Debt | 75.97K | 58.86K | 62.03K | 126K | 279K | |||||
Supplemental Operating Expense Items | ||||||||||
Selling and Marketing Expenses | 1.73M | 2.2M | 2.27M | 2.12M | 2.74M | |||||
General and Administrative Expenses | 2.28M | 2.81M | 2.93M | 4.16M | 7.16M | |||||
Research And Development Expense From Footnotes | - | - | - | - | - | |||||
Net Rental Expense, Total | 7K | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | 2.18K | - | - | - | - | |||||
Imputed Operating Lease Depreciation | 4.82K | - | - | - | - |
- Stock Market
- Stocks
- FIBRO Stock
- Financials Fibromat (M)
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















